Teva nasal allergy spray approved; Topical formulation of ibuprofen under development;

> The FDA approved Teva's ($TEVA) QNASL for the treatment of nasal symptoms of allergic rhinitis. The company says it is the first nasal allergy spray approved for children as young as four years old. It is a lower dose formulation of the medication meant for adults. Release

> Strategic Science and Technologies (SST) signed an agreement that gives an unnamed, large over-the-counter healthcare company an exclusive option to the obtain U.S. commercial rights to SST's topical formulation of ibuprofen once it gets approved by the FDA. Release